Frontiers
US$ 28.95
glp 1 for addiction treatment GLP-1 and Addiction: Clinical Trials Testing Ozempic Recovery Obesity drug cuts opiate craving
Description
Are liver markers improving
That aside, WW can no longer disassociate from weight-loss drugs
Received: Revised: Accepted: Published: Version of record: DOI:
10.2337/dc15-2383 53 HrndahlL.JingX.-J.IvarssonR.DegermanE.AhrnB.ManganielloV
Nolte, W
What differentiates winners in this space is no longer just weight loss percentage but mechanistic novelty, durability of effect, lean mass preservation, and patient-centric delivery (oral pills, monthly autoinjectors)
